
HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norov... HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.19 | 10.9826589595 | 1.73 | 1.985 | 1.67 | 217270 | 1.84128279 | CS |
4 | 0.01 | 0.523560209424 | 1.91 | 2.036 | 1.67 | 184064 | 1.86937522 | CS |
12 | 0 | 0 | 1.92 | 2.15 | 1.67 | 272171 | 1.94568702 | CS |
26 | 0.12 | 6.66666666667 | 1.8 | 2.15 | 1.67 | 243227 | 1.89768035 | CS |
52 | -13.23 | -87.3267326733 | 15.15 | 20.22 | 1.55 | 426270 | 3.59219455 | CS |
156 | -16.84 | -89.7654584222 | 18.76 | 24.42 | 1.55 | 215984 | 7.0142145 | CS |
260 | -16.84 | -89.7654584222 | 18.76 | 24.42 | 1.55 | 215984 | 7.0142145 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.